Papp K, Lebwohl M, Gottlieb A, Sebastian M, Langley R, Okubo Y, Wang M, Cioffi C, Staelens F, Reich K. Bimekizumab for the Treatment of Moderate to Severe Plaque Psoriasis with Scalp, Nail and Palmoplantar Involvement Through 52 Weeks: Post-Hoc Analysis from the BE VIVID Phase 3 Trial. J of Skin [Internet]. 2021Jan.1 [cited 2024Jul.3];5(1):s18. Available from: https://jofskin.org/index.php/skin/article/view/1171